A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues-Reference-Cited by-同舟云学术

A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues

Published:1988-04 Issue:4 Volume:24 Page:685-689
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Cunningham D.,Bradley C.J.,Forrest G.J.,Hutcheon A.W.,Adams L.,Sneddon M.,Harding M.,Kerr D.J.,Soukop M.,Kaye S.B.

Publisher

Elsevier BV

Subject

Oncology

Reference9 articles.

1. A randomised trial comparing intravenous high dose metoclopramide with intramuscular chlorpromazine in the control of nausea and vomiting induced by cytotoxic drugs;Cunningham;Br Med J,1985

2. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting;Gralla;N Engl J Med,1981

3. Optimizing metoclopramide control of cisplatin induced emesis;Meyer;Ann Inter Med,1984

4. The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum;Kerr;Br J Clin Pharmacol,1985

5. Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting;Allan;Br Med J,1984

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality;International Journal of Molecular Sciences;2024-06-06

2. Medical cannabis use in oncology and associated outcomes: A scoping review;Journal of Oncology Pharmacy Practice;2024-03-13

3. The chemistry and pharmacology of tetrahydrocannabinol and cannabidiol;Cannabis and Khat in Drug Discovery;2024

4. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer;Supportive Care in Cancer;2022-12-16

5. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications;BMC Medicine;2022-08-19